Viewing StudyNCT04425239



Ignite Creation Date: 2024-05-06 @ 2:47 PM
Last Modification Date: 2024-10-26 @ 1:37 PM
Study NCT ID: NCT04425239
Status: COMPLETED
Last Update Posted: 2022-04-07
First Post: 2020-05-03

Brief Title: Intermittent or Continuous Panitumumab Plus FOLFIRI for RASB-RAF Wild-type Metastatic Colorectal Cancer
Sponsor: National Cancer Institute Naples
Organization: National Cancer Institute Naples

Conditions & Keywords Data

Conditions:
Name
Colorectal Cancer Stage IV
Keywords:
Name View
panitumumab View
metastatic colorectal cancer View
RAS and BRAF wild type View
intermittent therapy View
liquid biopsy View